CU6 2.61% $5.22 clarity pharmaceuticals ltd

I’d say the data so far is indicating that 67Cu is inching ahead...

  1. 40 Posts.
    lightbulb Created with Sketch. 29
    I’d say the data so far is indicating that 67Cu is inching ahead of 177Lu when applied correctly.

    225Ac I feel is still a few years off and there may yet prove to be complex issues with toxicity and some bad side-effects, as seems to be the case currently.

    There will also be some significant commercial and logistics aspects that remain to affect the direction of the marker and these are yet to entirely play out. 177Lu is well-established now and has some growth to eventuate ahead of it, but scaleability is a real problem (1000 fold on setup costs). 225Ac and 67Cu won’t have these problems. It’s possible 67Cu becomes a preferred isotope (in some cases) due to commercial benefits (manufacturing setup costs and logistics) and low toxicity/side-effects, when applied to a good product (such as with 67Cu-SAR-bisPSMA), when compared with certain applications for 177Lu and 225Ac.
 
watchlist Created with Sketch. Add CU6 (ASX) to my watchlist
(20min delay)
Last
$5.22
Change
-0.140(2.61%)
Mkt cap ! $1.625B
Open High Low Value Volume
$5.36 $5.50 $5.18 $5.452M 1.028M

Buyers (Bids)

No. Vol. Price($)
1 6927 $5.22
 

Sellers (Offers)

Price($) Vol. No.
$5.26 4319 1
View Market Depth
Last trade - 16.10pm 14/06/2024 (20 minute delay) ?
Last
$5.22
  Change
-0.140 ( 1.59 %)
Open High Low Volume
$5.34 $5.49 $5.19 94951
Last updated 15.59pm 14/06/2024 ?
CU6 (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.